Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
9.65M
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
21.7M
-
Shares change
-
+21.7M
-
Total reported value, excl. options
-
$395M
-
Value change
-
+$395M
-
Number of buys
-
54
-
Price
-
$18.46
Significant Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q3 2020
54 filings reported holding ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value as of Q3 2020.
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.7M shares
.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.11M shares), RTW INVESTMENTS, LP (2.67M shares), VIKING GLOBAL INVESTORS LP (2.12M shares), VR Adviser, LLC (1.52M shares), Rock Springs Capital Management LP (1.1M shares), CITADEL ADVISORS LLC (1.08M shares), Avidity Partners Management LP (1.03M shares), Logos Global Management LP (1.02M shares), JANUS HENDERSON GROUP PLC (1M shares), and BAKER BROS. ADVISORS LP (882K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.